Intraocular RGD-Engineered Exosomes and Active Targeting of Choroidal Neovascularization (CNV) is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 67 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Presbyterian Health Foundation (PHF)
Grant: GRF 00003650
Presbyterian Health Foundation (PHF)
Grant: U54 GM104938
Presbyterian Health Foundation (PHF)
Grant: K12EY028873
Presbyterian Health Foundation (PHF)
Grant: SP20GM10363909
NEI NIH HHS
Grant: P30 EY021725
NEI NIH HHS
Grant: P30 EY029220
NEI NIH HHS
Grant: R56 EY034193
National Institutes of Health
Grant: 5K12EY028873-02
USC Roski Eye K12 Clinician-Vision Scientist Training Program (USC Roski Eye K12)
National Institutes of Health
Grant: 5U54GM104938-07
Oklahoma Shared Clinical and Translational Resources
FWCI
4.71
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals